Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|October 5, 2020
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous MelanomaFurong Zeng, Juan Su, Cong Peng, et al.Biomolecules|February 27, 2026
CXCR4: A Promising Novel Strategy for Lung Cancer TreatmentMengting Liao, Jianmin Wu, Tengkun Dai, et al.Advances in Therapy|March 21, 2020
Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung CancerDong Ding, Huabin Hu, Mengting Liao, et al.Medicine|August 30, 2019
Efficacy and safety of acupuncture therapy for chronic atrophic gastritis: A meta-analysis and trial sequential analysis protocolYuan Li, Yili Zhang, Han Meng, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 4, 2021
Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung CancerDong Ding, Huabin Hu, Shuosha Li, et al.Journal of Microbiology and Biotechnology|February 23, 2023
The Clinical Characteristic and Management of Patients with Nocardiosis in a Tertiary Hospital in ChinaPeilin Liu, Zhiqian Wang, Zijuan Jian, et al.Frontiers in Oncology|July 2, 2026
Decoding amino acid metabolism in hepatocellular carcinoma: critical nodes and novel therapeutic strategyJiayi Zhang, Yiling Zhu, Guiyan Liu, et al.Journal of Ethnopharmacology|April 16, 2021
The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studiesYan Chen, Fuhao Chu, Jie Lin, et al.Frontiers in Oncology|October 5, 2020
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung CancerHuabin Hu, Longjiang She, Mengting Liao, et al.Clinical and Translational Medicine|October 15, 2025
Targeting CLEC4E in immunosuppressive tumour-associated macrophages via BET inhibitionMengting Liao, Kexin Long, Liang Dong, et al.Pageof 4